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Post-traumatic stress disorder (PTSD) is a condition that appears to be becoming increasingly prevalent in psychiatric and general practice. Davidson (1992) repom a lifetime prevalence of 1-9% in the community, with high levels of chronicity and comorbidity. It routinely features in the general as well as medical literature following major traumas such as the Herald of Free Enterprise disaster. PTSD is also growing more important in medicolegal terms, as the recent police attempt to otirain compensation for their experiences in the Hillsborough tragedy demonstrates. Despite the high profile of the condition and the repeated descriptions of its development and (partial) resolution after every major disaster, there is very little research into the most effective means of preventing or treating PTSD. The usual approach of debriefing has been shown to be without effect (Deahl ef a1, 1994) and a recent review of drug treatments revealed only a few small-scale srudies, none of which would be suitable for the licensing of a drug for this disorder (Davidson, 1992) . This may be because most drug treatments are initiated well after the trauma, which may be too late to prevent the laying down of immutable brain traces for the memories, behaviours and affect that trauma causes and which develop into PTSD.
The need to improve the treatment of PTSD led us to explore the published literature relating brain mechanisms to the outcome of PTSD. We found a consistent theme dating back to the original studies of Adler that suggested brain trauma might protect from PTSD. As this is a rather surprising observation we thought it important to bring it to the knowledge of psychiatric and other professionals involved in the treatment of people with PTSD. In addition, as it potentially offers a new insight into the nature and treatment of PTSD, we briefly review the brain mechanisms which may be responsible.
U N C O N S C I O U S N E S S A N D PTSD
Obviously, loss of consciousness that leads to the absence of any memory of an incident means that the patient will not have any horrific memories, flashbacks or nightmares and so will not re-experience the incident repeatedly. This may prevent the progressive activation of other brain circuits rhat together form the brain s u b strate for PnD.
Furthermore, the lack of memory means that there is less reason to avoid the relevant cues to the event and this probahly results in less avoidance.
The literature from the 1940s and 1950s first described the post-rraumatic syndrome as we recognise it (Adler, 1943) . In her follow-up of patients from the Coconut Grove Disaster. she noted that:
-ofthe 20 patrents who d~d not develop psychlatric complicattons. 15 had lost consctousness. which wlth I2 ofthe 15 was prolonged beyond one hour. Of the 25 w~t h psychtatrtc compltcations. 13 had lost consciousness. Thls however was short, below one hour In 10 of the I3 cases.-In other words, unconsciousness, especially if prolonged for more than one hour, improved outcome.
Since that time there have been only a few reports rhat have examined this issue. Adler herself noted in another series of patients:
'that In only one of etght pattents wtth a retrograde amnewa of more than an hour dtd psychogentc symptoms develop-(Adler. 19459, Much later, hlcMillan (1991) in a single case study of a road traffic accident victim suggested that PTSD can occur even where there is loss of consciousness and organic amnesia for the event and its immediate sequelae. However, the importance of coma as a protective element has been revived by the recent work by Mayou and colleagues in Oxford (Mayou et al, 1993). Their study on the psychiatric consequences of road traffic accidents showed rhat post-traumatic syndromes were strongly associated with horrific memories of the accident; they did not occur in any suhjea who had been unconscious and were amnesic for the accident.
Why might this be? Adler took a psychodynamic view, wondering if:
'prolonged unconsciousness rnsght prevent psych~atrtc compltcat+ons follmng terr~fylng events.
but not In patterns tn whom unresolved confltcts were to form the baws of post-traumat~c dtfficulttes' (Adler. 19450)
B R A I N M E C H A N I S M S
Unconsciousness following trauma can be the result of a number of factors. Brain trauma (concussion) is the most common, but others include: spinal trauma, hypoxia, hypovolaemia, chemical intoxicants such as noxious vapours. simple fainting and possibly dissociation. Virtually nothing is known about the brain sequelae of any of these. except concussion. which is thought to he due to the disruption of ascending pathways from brain stem to cortex due to a combination of neuron shearing and oedema-induced increases in intra-cerebral pressure. These pathways are primarily glutamatergic although ascending monoamine fibres are probably also involved. Glutamate is the primary excitatory transmitter in the brain and is intimately involved in consciousness and memory (Collingridge & Bliss, 1995) . It is thought that stressors are registered and remembered when they lead to enough glutamate release to activate N-methyl-D-aspartate (N,MDA) receptors which then produce long-term memories (Glue et al, 1993) . Disruption of glutamate transmission will therefore prevent memory and probably the other brain changes that result from a suessor.
Unconsciousness can also be produced by increasing inhibition in the brain. The primary inhibitory transmitter in the brain is gamma-aminobutyric acid (GABA), acting through the GABA-A receptor. Activating this receptor either by the endogenous transmitter or by drugs such as the benzodiazepines, barbiturates and anaesthetics (e.g. propofol), renders people unconscious and at lower concentrations amnestic. It is not known if GABA is released in response to brain trauma, although the local nature of the GARA system means these neurons are unlikely to he damaged by trauma and so i n the face o f reduced glutamate release even normal GABA release could lead t o coma.
There is now good evidence for endogenous benzodiazepine-like molecules and neurosteroids which act at modulatory sites o n the GABA-receptor complex and potentiate the actions o f GABA. There is evidence that these are released by stressors and have been suggested t o serve a role in reducing anxiety; perhaps they also contribute to limiting memory and it may be rhey contribute t o dissociative states (Izquierdol & Medina, 1991 
IMPLICATIONS, FOR TREATMENT
If loss o f consciousness protects from PTSD by preventing the encoding o f traumatic memories could this be a route t o new treatments? A number o f amnestic agents are currently available and some have a good track record i n preventing military stress leading t o breakdown and later PTSD. For some time military doctors have used heavy sedation with barbiturates, and more recently benzodiazepines, r o deal with acutely 'shell-shocked' individuals. Many non-military trauma casualties have been treated i n the same way, although there appears never t o have been a controlled study o f this sort o f intervention. Moreover, the exaggerated recent concern over the perceived dangers o f benzodiazepines has frightened many doctors into not using them in traumatised patients. One suspects that this makes PTSD more likely because the benzodiazepine actions t o promote sleep and reduce anxiety should decrease the repeated reliving o f the traumatic image and so reduce the depth t o which it becomes embedded i n memory. The only placebo-controlled study o f a benzodiazepine (alprazolam) i n PTSD showed no effect on core symptoms, though anxiety and well-being were improved (Braun et al,  1990 ). These patients all had long-standing PTSD so the benzodiazepine treatment was started far too late t o test our theory. In practice, many sufferers turn t o another redative -alcohol. This acts like a benzodiazepine t o increase CABA function and also blocks some aspects o f glutamate transmission ( N u n & Peters. 1994) , which could suggest it would have better efficacy than the knzodiazepines, although the toxic side-effects and its short duration o f acrion would make controlled studies difficult.
One of the critical issues is whether coma is required o r just complete amnesia. The available data are too sparse t o be o f use; however, amnestic agents such as the benzodiazepines and barbiturates, while producing a profound anterograde amnesia (for events after they have been taken), have relatively little effect on the memory for prior events (retrograde amnesia). Indeed, there is some evidence that by blocking the formation o f new memories rhey facilitate ones just prior t o their administration. Other d r u g such as hyoscine have greater anterograde effects and it might be interesting t o combine these with benzodiazepines t o more closely mimic the effects o f coma. Similarly, a combination of clonidine and benzodiazepine could be more effective than a benzodiazepine alone.
In the light o f the possibility that endogenous anxiety-producing benzodiazepines are released by trauma (Davidson et al, 1988) . it may be that a benzodiazepine receptor antagonist such as flumazenil might be o f use. This has never been tried i n acute PTSD but perhaps should k as it is safe and i n some patients anxiolytic in chronic PTSD (Randall et al. 1995 : Coupland et al, 1997 .
It is a real possibility that we can devise treatments that work through the glutamate system, as antagonists for all three main classes o f glutamate receptor now exist. Some such as dizolcilpine (MKSOI) have been used in humans as potential antibrain ischaemia agents and do produce a state o f reduced sensory input similar t o dissociation. Further work is needed t o determine whether this and related compounds have anti-stress and retrograde memory blocking properties. Animal experiments such as those o f Adamec (1998) have shown that N M D A antagonists can block both the behavioural and neurophysiological changes i n a model o f PTSD.
Finally, there is good evidence that the brain's endogenous opioid system (e.g. the endorphins) is activated by sucss, and serves a compensatory role at least in terms o f pain reduction. There is now preliminary evidence that supporting this system, with synthetic agonists such as buprenorphine, is therapeutically useful i n PTSD (Mongan & Calloway, 1990) . It is possible that a combination o f opioid and amnestic agents might be especially effective.
The evidence that brain trauma and its resultant impairment o f conxioumess can have a paradoxical beneficial effect on the psychological recovery from trauma. This may be explained i n terms o f the failure o f trauma memory consolidation secondary t o alterations i n key neurotransmitters. These observations offer the hope o f new therapeutic approaches t o the prevention o f PTSD.
